珂 董

Ms. 珂 董

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Biology
Verified
Journal Article
Open access
PDF file
珂董珂 董
珂 董
BLBing Liu
Bing Liu
GCGang Cheng
Gang Cheng
YLYang Li
Yang Li
FXFang Xie
Fang Xie
LQLingjia Qian
Lingjia Qian
Stress is a non-specific systemic response to internal or external challenges. Recent studies show that stress can disrupt iron metabolism and that iron dyshomeostasis is implicated in many diseases-particularly within the nervous system, where iron distribution and regulation intersect tightly with oxidative stress and inflammation. Activation of the hypothalamic–pituitary–adrenal (HPA) axis by stress can upregulate hepatic hepcidin and reprogram systemic iron fluxes, leading to functional iron deficiency and, in the brain, reduced iron availability, which affects myelination and neurotransmitter metabolism. Conversely, iron dyshomeostasis also contributes to neurodegenerative pathology. In this review, we synthesize recent evidence of how stress reprograms brain iron distribution and regulation, and we outline the mechanistic links between stress-induced iron dysregulation and neurological pathology. We also discuss the therapeutic implications (such as iron-chelation strategies) and highlight the three-way interplay among stress, iron metabolism, and neurodegeneration. These insights suggest that managing iron homeostasis may offer new therapeutic avenues for stress-related neural disorders.

30 October 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
BLBing Liu
Bing Liu
珂董珂 董
珂 董
XCXiaobing Chen
Xiaobing Chen
HDHuafeng Dong
Huafeng Dong
YZYun Zhao
Yun Zhao
LQLingjia Qian
Lingjia Qian
Background: Growing evidence suggests that glucose metabolism plays a crucial role in activated immune cells, significantly contributing to the occurrence and development of neuroinflammation and depression-like behaviors. Chronic stress has been reported to induce microglia activation and disturbances in glucose metabolism in the hippocampus. Aims: This study aims to investigate how chronic stress-mediated glycolysis promotes neuroinflammation and to assess the therapeutic potential of the glycolysis inhibitor, 2-deoxy-D-glucose (2-DG), in a model of chronic stress-induced neuroinflammation and depression-like behavior. Methods: In in vitro studies, we first explored the effects of 2-DG on the inflammatory response of microglia cells. The results showed that corticosterone (Cort) induced reactive oxygen species (ROS) production, increased glycolysis, and promoted the release of inflammatory mediators. However, these effects were reversed by intervention with 2-DG. Subsequently, we examined changes in depression-like behavior and hippocampal glycolysis in mice during chronic stress. The results indicated that chronic stress led to prolonged escape latency in the Morris water maze, increased platform-crossing frequency, reduced sucrose preference index, and extended immobility time in the forced swim test, all of which are indicative of depression-like behavior in mice. Additionally, we found that the expression of the key glycolytic enzyme hexokinase 2 (HK2) was upregulated in the hippocampus of stressed mice, along with an increased release of inflammatory factors. Further in vivo experiments investigated the effects of 2-DG on glycolysis and pro-inflammatory mediator production, as well as the therapeutic effects of 2-DG on chronic stress-induced depression-like behavior in mice. The results showed that 2-DG alleviated chronic stress-induced depression-like behaviors, such as improving escape latency and platform-crossing frequency in the Morris water maze, and increasing the time spent in the center of the open field. Additionally, 2-DG intervention reduced the level of glycolysis in the hippocampus and decreased the release of pro-inflammatory mediators. Conclusions: These findings suggest that 2-DG can mitigate neuroinflammation and depressive behaviors by inhibiting glycolysis and inflammatory responses. Overall, our results highlight the potential of 2-DG as a therapeutic agent for alleviating chronic stress-induced neuroinflammation through the regulation of glycolysis.

8 March 2025 in Cells
Verified
Journal Article
Open access
PDF file
BLBing Liu
Bing Liu
珂董珂 董
珂 董
YZYun Zhao
Yun Zhao
XWXue Wang
Xue Wang
ZSZhao-Wei Sun
Zhao-Wei Sun
LQLingjia Qian
Lingjia Qian
Advanced glycation end products (AGEs) are a series of structurally complex and harmful compounds formed through the reaction between the carbonyl group of reducing sugars (such as glucose and fructose) and the free amino groups of proteins, lipids, or nucleic acids. Excessive accumulation of AGEs in the body can trigger oxidative stress, induce inflammatory responses, and contribute to the development of diabetes, atherosclerosis, and neurological disorders. Within the category of dicarbonyl compounds, methylglyoxal (MGO)—a byproduct resulting from glucose degradation—serves as a pivotal precursor in the formation of AGEs and the induction of neurotoxicity. Specifically, AGEs generated from MGO display significant cytotoxicity toward cells in the central nervous system. Therefore, we aimed to investigate the role of MGO-AGEs in neuroinflammation mediated by CUMS. Interestingly, we found that the overexpression of glyoxalase 1 (GLO1) reduced the levels of MGO in corticosterone-treated microglia, thereby alleviating the inflammatory response. Furthermore, overexpression of GLO1 in the hippocampus of chronically stressed mice reduced MGO levels, mitigating CUMS-induced neuroinflammation and cognitive impairment. Additionally, when using the receptor for advanced glycation end products (RAGE) inhibitor FPS-ZM1 in primary microglia cells, we observed that despite corticosterone-induced elevation of MGO, no significant inflammatory response occurred. This suggests that RAGE clearance can reduce MGO-AGE-mediated neurotoxicity. Subsequently, we used FPS-ZM1 to treat chronically stressed mice and found that it significantly ameliorated neuroinflammation and cognitive dysfunction. These results suggest that targeting MGO metabolism could serve as a therapeutic approach to manage neuroinflammation in stress-related mental disorders.

8 October 2026 in Biology
Verified
Journal Article
Open access
PDF file
BLBing Liu
Bing Liu
FXFang Xie
Fang Xie
珂董珂 董
珂 董
WMWang yu Meng
Wang yu Meng
LZLing Zhang
Ling Zhang
JZJianning Zhang
Jianning Zhang
Polytrauma induces neuroendocrine, inflammatory, neurological, and multiorgan responses that may follow distinct temporal trajectories. We characterized these changes during the first 7 days after experimental head–thorax–abdomen polytrauma in male C57BL/6 mice. Animals underwent polytrauma or Sham procedures and were evaluated at 0 h, 3 h, 6 h, 12 h, 24 h, 3 d and 7 d. Neurological and behavioral outcomes, brain water content, serum and injured-brain neuroendocrine and inflammatory mediators, and brain, lung, and liver histopathology were assessed. Polytrauma caused persistent neurological and locomotor impairment and increased brain water content. Corticosterone rose rapidly during the early phase and largely normalized by 12 h, whereas norepinephrine in injured brain tissue increased at 3–7 d. Pro- and anti-inflammatory mediators showed distinct systemic and cerebral temporal profiles. Histology demonstrated time-dependent brain, lung, and liver injury with evolving extracellular matrix remodeling. Thus, experimental polytrauma produces temporally dissociated responses characterized by early glucocorticoid activation, persistent neurological and inflammatory abnormalities, delayed cerebral noradrenergic changes, and progressive multiorgan remodeling, supporting phase-specific pathophysiology after injury.